In recent years, oxidative stress has been implicated in a variety of degenerative processes, diseases, and syndromes. Some of these include atherosclerosis, myocardial infarction, stroke, and ischemia/reperfusion injury; chronic and acute inflammatory conditions such as wound healing; central nervous system disorders such as forms of familial amyotrophic lateral sclerosis (ALS) and glutathione peroxidase-linked adolescent seizures; Parkinson’s disease and Alzheimer’s dementia; and a variety of other age-related disorders. Among the various biochemical events associated with these conditions, emerging evidence suggests the formation of superoxide anion and expression/activity of its endogenous scavenger, superoxide dismutase (SOD), as a common denominator. This review summarizes the function of SOD under normal physiological conditions as well as its role in the cellular and molecular mechanisms underlying oxidative tissue damage and neurological abnormalities. Experimental evidence from laboratory animals that either overexpress (transgenics) or are deficient (knockouts) in antioxidant enzyme/protein levels and the genetic SOD mutations observed in some familial cases of ALS are also discussed.
Adams JD Jr, Odunze IN. 1991. Oxygen free radicals and Parkinson’s disease. Free Radical Biology and Medicine10:161-169.
2.
Al-Chalabi A, Leigh PN. 2000. Recent advances in amyotrophic lateral sclerosis. Current Opinion in Neurology13:397-405.
3.
Andreassen OA, Ferrante RJ, Dedeoglu A, Albers DW, Klivenyi P, Carlson EJ, Epstein CJ, Beal MF. 2001. Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP. Exp Neurol167:189-195.
4.
Beal MF. 1994a. Energy, oxidative damage, and Alzheimer’s disease: clues to the underlying puzzle. Neurobiol Aging15:S171-S174.
5.
Beal MF. 1994b. Neurochemistry and toxin models in Huntington’s disease. Curr Opin Neurol7:542-547.
6.
Beckman J, Crow J, Estevez A. Forthcoming. Peroxynitrite and injury to the vasculature and central nervous system in stroke and neurodegeneration. In: Chan PH, editor. Twenty second Princeton conference on cerebrovascular disease. Cambridge (UK): Cambridge University Press.
7.
Benov L, Sztejnberg L., Fridovich I.1998. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radical Biology and Medicine25:826-831.
8.
Bordet R, Deplanque D, Maboudou P, Puisieux F, Pu Q, Robin E, Martin A, Bastide M, Leys D, Lhermitte M, Dupuis B.2000. Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance. J Cereb Blood Flow Metab20:1190-1196.
9.
Bowling AC, Beal MF. 1995. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci56:1151-1171.
10.
Brorson JR, Schumacker PT, Zhang H.1999. Nitric oxide acutely inhibits neuronal energy production. The Committees on Neurobiology and Cell Physiology. J Neurosci19:147-158.
11.
Brown RH Jr.1996. Superoxide dismutase and familial amyotrophic lateral sclerosis: new insights into mechanisms and treatments. [letter; comment]. Ann Neurol39:145-146.
12.
Calabresi P, Gubellini P, Picconi B, Centonze D, Pisani A, Bonsi P, Greengard P, Hipskind RA, Borrelli E, Bernardi G.2001. Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. J Neurosci21:5110-5120.
13.
Chan P, Langston JW, Irwin I, DeLanney LE, Di Monte DA. 1993. 2-deoxyglucose enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ATP loss in the mouse brain. J Neurochem61:610-616.
14.
Chan PH, Kawase M, Murakami K, Chen SF, Li Y, Calagui B, Reola L, Carlson E, Epstein CJ. 1998. Overexpression of SOD1 in trans genic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J Neurosci18:8292-8299.
15.
Cheeseman KH, Slater TF. 1993. An introduction to free radical biochemistry. British Medical Bulletin49:481-493.
16.
Chou SM, Han CY, Wang HS, Vlassara H, Bucala R.1999. A receptor for advanced glycosylation endproducts (AGEs) is colocalized with neurofilament-bound AGEs and SOD1 in motoneurons of ALS: immunohistochemical study. J Neurol Sci169:87-92.
17.
Delacourte A, Defossez A, Ceballos I, Nicole A, Sinet PM. 1988. Preferential localization of copper zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer’s disease. Neurosci Lett92:247-253.
18.
Dirnagl U, Lindauer U, Them A, Schreiber S, Pfister HW, Koedel U, Reszka R, Freyer D, Villringer A.1995. Global cerebral ischemia in the rat: online monitoring of oxygen free radical production using chemiluminescence in vivo. J Cereb Blood Flow Metab15:929-940.
19.
d’Uscio LV, Baker TA, Mantilla CB, Smith L, Weiler D, Sieck GC, Katusic ZS. 2001. Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol21:1017-1022.
20.
Enghild JJ, Thogersen IB, Oury TD, Valnickova Z, Hojrup P, Crapo JD. 1999. The heparin-binding domain of extracellular superoxide dismutase is proteolytically processed intracellularly during biosynthesis. J Biol Chem274:14818-14822.
21.
Fujimura M, Gasche Y, Morita-Fujimura Y, Massengale J, Kawase M, Chan PH. 1999a. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res842:92-100.
22.
Fujimura M, Morita-Fujimura Y, Kawase M, Copin JC, Calagui B, Epstein CJ, Chan PH. 1999b. Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome C and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. J Neurosci19:3414-3422.
23.
Garcia JH, Liu KF, Yoshida Y, Lian J, Chen S, del Zoppo GJ. 1994. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol144:188-199.
24.
Gasche Y, Copin JC, Sugawara T, Fujimura M, Chan PH. 2001. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab21:1393-1400.
25.
Gehrmann J, Banati RB, Wiessner C, Hossmann KA, Kreutzberg GW. 1995. Reactive microglia in cerebral ischaemia: an early mediator of tissue damage?Neuropathol Appl Neurobiol21:277-289.
26.
[see comments] [published erratum appears in Science1995 Jul 14;269(5221):149]. Science264:1772-1775.
27.
Hoffstein ST, Gennaro DE, Manzi RM. 1985. Neutrophils may directly synthesize both H2O2 and O2- since surface stimuli induce their release in stimulus-specific ratios. Inflammation9:425-437.
28.
Huang CY, Fujimura M, Noshita N, Chang YY, Chan PH. 2001. SOD1 down-regulates NF-kappaB and c-Myc expression in mice after transient focal cerebral ischemia. J Cereb Blood Flow Metab21:163-173.
29.
Husain J, Juurlink BH. 1995. Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species. Brain Res698:86-94.
Jung C, Rong Y, Doctrow S, Baudry M, Malfroy B, Xu Z.2001. Synthetic superoxide dismutase/catalase mimetics reduce oxidative stress and prolong survival in a mouse amyotrophic lateral sclerosis model. Neurosci Lett304:157-160.
33.
Kajita Y, Suzuki Y, Oyama H, Tanazawa T, Takayasu M, Shibuya M, Sugita K.1994. Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. J Neurosurg80:476-483.
34.
Kamii H, Kato I, Kinouchi H, Chan PH, Epstein CJ, Akabane A, Okamoto H, Yoshimoto T.1999. Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke30:867-871; discussion 872.
35.
Kamii H, Mikawa S, Murakami K, Kinouchi H, Yoshimoto T, Reola L, Carlson E, Epstein CJ, Chan PH. 1996. Effects of nitric oxide synthase inhibition on brain infarction in SOD-1-transgenic mice following transient focal cerebral ischemia. J Cereb Blood Flow Metab16:1153-1157.
36.
Kasapoglu M, Ozben T.2001. Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp Gerontol36:209-220.
37.
Kato H, Kogure K, Araki T, Liu XH, Kato K, Itoyama Y.1995. Immunohistochemical localization of superoxide dismutase in the hippocampus following ischemia in a gerbil model of ischemic tolerance. J Cereb Blood Flow Metab15:60-70.
38.
Katsuki H, Tomita M, Takenaka C, Shirakawa H, Shimazu S, Ibi M, Kume T, Kaneko S, Akaike A.2001. Superoxide dismutase activity in organotypic midbrain-striatum co-cultures is associated with resistance of dopaminergic neurons to excitotoxicity. J Neurochem76:1336-1345.
39.
Kinouchi H, Epstein CJ, Mizui T, Carlson E, Chen SF, Chan PH. 1991. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci U S A88:11158-11162.
40.
Kondo T, Reaume AG, Huang TT, Carlson E, Murakami K, Chen SF, Hoffman EK, Scott RW, Epstein CJ, Chan PH. 1997. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci17:4180-4189.
41.
Lewen A, Matz P, Chan PH. 2000. Free radical pathways in CNS injury. J Neurotrauma17:871-890.
42.
Lindenau J, Noack H, Possel H, Asayama K, Wolf G.2000. Cellular distribution of superoxide dismutases in the rat CNS. Glia29:25-34.
43.
Liu XH, Kato H, Nakata N, Kogure K, Kato K.1993. An immunohistochemical study of copper/zinc superoxide dismutase and manganese superoxide dismutase in rat hippocampus after transient cerebral ischemia. Brain Res625:29-37.
44.
MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. 1996. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci U S A93:11853-11858.
45.
Maier CM, Ahern K, Cheng ML, Lee JE, Yenari MA, Steinberg GK. 1998. Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischemia: effects on neurologic outcome, infarct size, apoptosis, and inflammation. Stroke29:2171-2180.
46.
Maier CM, Sun GH, Cheng D, Yenari MA, Chan PH, Steinberg GK. In press. Effects of mild hypothermia on superoxide anion production, superoxide dismutase expression and activity following transient focal cerebral ischemia. Neuroscientist.
47.
Marchington DR, Barlow D, Poulton J.1999. Transmitochondrial mice carrying resistance to chloramphenicol on mitochondrial DNA: developing the first mouse model of mitochondrial DNA disease. Nat Med5:957-960.
48.
Marklund SL, Adolfsson R, Gottfries CG, Winblad B.1985. Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type. J Neurol Sci67:319-325.
49.
Matsuyama T, Michishita H, Nakamura H, Tsuchiyama M, Shimizu S, Watanabe K, Sugita M.1993. Induction of copper-zinc superoxide dismutase in gerbil hippocampus after ischemia. J Cereb Blood Flow Metab13:135-144.
50.
Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, Jun AS, Zastawny TH, Dizdaroglu M, Goodman SI, Huang TT, Miziorko H, Epstein CJ, Wallace DC. 1999. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A96:846-851.
51.
Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL. 1998. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circulation Research82:1298-1305.
52.
Morita-Fujimura Y, Fujimura M, Gasche Y, Copin JC, Chan PH. 2000. Overexpression of copper and zinc superoxide dismutase in transgenic mice prevents the induction and activation of matrix metal-loproteinases after cold injury-induced brain trauma. J Cereb Blood Flow Metab20:130-138.
53.
Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF, Chan PH. 1998. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci18:205-213.
54.
Nakane H, Chu Y, Faraci FM, Oberley LW, Heistad DD. 2001. Gene transfer of extracellular superoxide dismutase increases superoxide dismutase activity in cerebrospinal fluid. Stroke32:184-189.
55.
Nakao N, Frodl EM, Widner H, Carlson E, Eggerding FA, Epstein CJ, Brundin P.1995. Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson’s disease. Nat Med1:226-231.
56.
Noshita N, Sugawara T, Fujimura M, Morita-Fujimura Y, Chan PH. 2001. Manganese superoxide dismutase affects cytochrome c release and caspase-9 activation after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab21:557-567.
57.
Peters O, Back T, Lindauer U, Busch C, Megow D, Dreier J, Dirnagl U.1998. Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab18:196-205.
58.
Pfister HW, Koedel U, Lorenzl S, Tomasz A.1992. Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats. Stroke23:1798-1804.
59.
Phillis JW. 1994. A “radical” view of cerebral ischemic injury. Progress in Neurobiology42:441-448.
60.
Pineda JA, Aono M, Sheng H, Lynch J, Wellons JC, Laskowitz DT, Pearlstein RD, Bowler R, Crapo J, Warner DS. 2001. Extracellular superoxide dismutase overexpression improves behavioral outcome from closed head injury in the mouse. J Neurotrauma18:625-634.
61.
Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, O’Halloran TV. 1999. Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science284:805-808.
62.
[published erratum appears in Nature1993 Jul 22;364(6435):362] [see comments]. Nature362:59-62.
Sheng H, Kudo M, Mackensen GB, Pearlstein RD, Crapo JD, Warner DS. 2000. Mice overexpressing extracellular superoxide dismutase have increased resistance to global cerebral ischemia. Exp Neurol163:392-398.
65.
Siesjo BK, Elmer E, Janelidze S, Keep M, Kristian T, Ouyang YB, Uchino H.1999. Role and mechanisms of secondary mitochondrial failure. Acta Neurochir Suppl73:7-13.
66.
Sugawara T, Noshita N, Lewen A, Gasche Y, Ferrand-Drake M, Fujimura M, Morita-Fujimura Y, Chan PH. 2002. Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation. J Neurosci. 22:209-217.
67.
Uyama O, Matsuyama T, Michishita H, Nakamura H, Sugita M.1992. Protective effects of human recombinant superoxide dismutase on transient ischemic injury of CA1 neurons in gerbils. Stroke23:75-81.
68.
Williamson TL, Cleveland DW. 1999. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nature Neurosci2:50-56.
69.
Wong PC, Waggoner D, Subramaniam JR, Tessarollo L, Bartnikas TB, Culotta VC, Price DL, Rothstein J, Gitlin JD. 2000. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc Natl Acad Sci U S A97:2886-2891.
70.
Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, Epstein CJ, Kamii H.1994. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke25:165-170.
71.
Zhang Y, Marcillat O, Giulivi C, Ernster L, Davies KJ. 1990. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem265:16330-16336.
